According to Biomerica's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.83054. At the end of 2023 the company had a P/S ratio of 2.84.
Year | P/S ratio | Change |
---|---|---|
2023 | 2.84 | -9.63% |
2022 | 3.15 | -45.05% |
2021 | 5.73 | -54.99% |
2020 | 12.7 | 123.94% |
2019 | 5.68 | 19.07% |
2018 | 4.77 | -2.12% |
2017 | 4.88 | 53.96% |
2016 | 3.17 | 143.23% |
2015 | 1.30 | -3.09% |
2014 | 1.34 | 5.01% |
2013 | 1.28 | 45.11% |
2012 | 0.8817 | 50.94% |
2011 | 0.5841 | 16.15% |
2010 | 0.5029 | -3.27% |
2009 | 0.5199 | -36.31% |
2008 | 0.8163 | -50.75% |
2007 | 1.66 | 207.91% |
2006 | 0.5383 | 92.56% |
2005 | 0.2795 | 13.16% |
2004 | 0.2470 | -9.54% |
2003 | 0.2731 | 79.01% |
2002 | 0.1526 | -61.93% |
2001 | 0.4007 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Align Technology
ALGN | 5.61 | 206.73% | ๐บ๐ธ USA |
Dentsply Sirona
XRAY | 1.49 | -18.56% | ๐บ๐ธ USA |
Biolase
BIOL | 0.1196 | -93.47% | ๐บ๐ธ USA |